News

Published on 4 Mar 2022 on Zacks via Yahoo Finance

The Zacks Analyst Blog Highlights Moderna, Gilead Sciences, Kodiak Sciences and Lexicon...

Article preview image

For Immediate Release

Chicago, IL – March 4, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Moderna MRNA, Gilead Sciences, Inc. GILD, Kodiak Sciences Inc. KOD and Lexicon Pharmaceuticals, Inc. LXRX.

Here are highlights from Thursday’s Analyst Blog:

Read the rest of the article
NASDAQ.MRNA price evolution
NASDAQ.LXRX price evolution
NASDAQ.KOD price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Moderna stock gains on OpenAI deal (NASDAQ:MRNA)

Moderna (MRNA) stock gains as company announces a deal with AI company OpenAI to accelerate the d...

Seeking Alpha 24 Apr 2024
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown -...

Moderna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London p...

Benzinga 23 Apr 2024
Insiders At Moderna Sold US$3.3m In Stock, Alluding To Potential Weakness

In the last year, many Moderna, Inc. (NASDAQ:MRNA) insiders sold a substantial stake in the compa...

Simply Wall St. via Yahoo Finance 21 Apr 2024
Moderna director Noubar Afeyan sells over $1.5 million in stock By Investing.com

Moderna , Inc. (NASDAQ:MRNA) Director Noubar Afeyan has sold a total of $1,550,703 worth of compa...

Investing.com 19 Apr 2024
Top Analyst Reports for Costco, NIKE & Fiserv

Friday, April 19, 2024 The Zacks Research Daily presents the best research output of our analyst ...

Zacks via Yahoo Finance 19 Apr 2024
Moderna stock traded in the red for the eighth straight day (NASDAQ:MRNA)

The stock closed down 0.58% at $101.41. MRNA has lost about 29.6% in the last 12 months and YTD, ...

Seeking Alpha 19 Apr 2024
Investing in Moderna (NASDAQ:MRNA) five years ago would have delivered you a 367% gain

For many, the main point of investing in the stock market is to achieve spectacular returns. Whil...

Simply Wall St. via Yahoo Finance 13 Apr 2024
Moderna director Noubar Afeyan sells over $1.6m in company stock By Investing.com

In a recent transaction, Noubar Afeyan, a director at Moderna , Inc. (NASDAQ:MRNA), sold a...

Investing.com 13 Apr 2024
Moderna (MRNA) Surges 6.2%: Is This an Indication of Further Gains?

Moderna MRNA shares ended the last trading session 6.2% higher at $111.60. The jump came on an im...

Zacks via Yahoo Finance 10 Apr 2024
What made Moderna stock pop 10% on Tuesday?

Jefferies analyst made positive remarks on MRNA-4157 today. Moderna stock is now up close to 30% ...

Invezz 9 Apr 2024

Copyright Statfolio @ 2024

Social Accounts